1 research outputs found
Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT
This study was supported in part by the Spanish grant of Instituto de Salud Carlos III (PI16/01485) and FEDER European Union.Peer reviewe